Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -1.60%-509K | -8.00%-567K | -1.80%-622K | 12.20%-2.11M | 17.66%-471K | 34.25%-501K | 3.67%-525K | -17.05%-611K | -6.19%-2.4M | -20.42%-572K |
| Net income from continuing operations | -235.39%-815K | 49.93%-375K | 38.34%-497K | 11.25%-2.97M | -30.98%-1.17M | 76.84%-243K | -1.08%-749K | -22.12%-806K | 16.29%-3.34M | 18.70%-891K |
| Operating gains losses | 180.07%225K | -1,000.00%-324K | -249.11%-167K | -506.35%-256K | -183.11%-123K | -639.47%-281K | 300.00%36K | 300.00%112K | -54.35%63K | 197.37%148K |
| Depreciation and amortization | --5K | 2,500.00%26K | --0 | -60.00%2K | --0 | --0 | 0.00%1K | 0.00%1K | 0.00%5K | 100.00%2K |
| Remuneration paid in stock | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -41.82%480K | ---- |
| Remuneration paid in stock | --0 | --0 | --0 | -78.80%67K | -95.00%2K | -93.33%3K | -72.34%26K | -73.72%36K | -60.94%316K | -77.65%40K |
| Other non cashItems | -188.37%-124K | 18.18%143K | 9.02%133K | 728.33%994K | 319.34%794K | -113.92%-43K | 13.08%121K | 84.85%122K | 445.45%120K | -44.22%-362K |
| Change In working capital | 217.46%200K | -192.50%-37K | -19.74%-91K | 213.64%50K | 109.09%23K | 310.00%63K | 366.67%40K | -660.00%-76K | 36.23%-44K | -42.11%11K |
| -Change in receivables | 101.89%16K | -34.29%23K | -32.53%-110K | -184.21%-16K | 2,207.89%877K | -7,141.67%-845K | 16.67%35K | -36.07%-83K | 480.00%19K | 153.33%38K |
| -Change in payables and accrued expense | -79.74%184K | -1,300.00%-60K | 171.43%19K | 204.76%66K | -3,062.96%-854K | 2,261.90%908K | 111.11%5K | -86.27%7K | 1.56%-63K | -775.00%-27K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -1.60%-509K | -8.00%-567K | -1.80%-622K | 12.20%-2.11M | 17.66%-471K | 34.25%-501K | 3.67%-525K | -17.05%-611K | -6.19%-2.4M | -20.42%-572K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -68.88%-2.34M | -152.50%-1.64M | 121.15%605K | 53.11%-3.07M | 67.89%-1.95M | -144.27%-1.39M | 34,611.11%3.12M | -3,864.47%-2.86M | -11,796.36%-6.54M | -6.06M |
| Net PPE purchase and sale | -41.42%-1.98M | -85.78%-1.65M | 16.90%-2.38M | -5.76%-7.11M | 67.79%-1.96M | -129.18%-1.4M | -2,431.43%-886K | -143,350.00%-2.87M | -7,539.77%-6.72M | -33,655.56%-6.08M |
| Net business purchase and sale | --0 | ---- | ---- | --4M | --0 | --0 | ---- | ---- | --0 | --0 |
| Net investment purchase and sale | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- |
| Interest received (cash flow from investment activities) | -53.85%6K | -40.00%6K | 0.00%8K | -76.67%42K | -26.67%11K | -69.77%13K | -77.27%10K | -89.74%8K | 445.45%180K | -16.67%15K |
| Net other investing changes | ---368K | --0 | --2.98M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -68.88%-2.34M | -152.50%-1.64M | 121.15%605K | 53.11%-3.07M | 67.89%-1.95M | -144.27%-1.39M | 34,611.11%3.12M | -3,864.47%-2.86M | -11,796.36%-6.54M | ---6.06M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -6K | 4.56M | -6K | 0 | 0 | 0 | ||||
| Net issuance payments of debt | ---6K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net common stock issuance | --0 | ---- | ---- | --4.87M | --295K | --0 | ---- | ---- | --0 | --0 |
| Cash dividends paid | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Interest paid (cash flow from financing activities) | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net other financing activities | ---- | ---- | ---- | ---301K | ---- | ---- | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---6K | ---- | ---- | --4.56M | ---6K | --0 | ---- | ---- | --0 | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | -58.05%4.82M | 60.78%6.9M | -14.63%6.82M | -52.39%7.99M | -29.60%9.97M | -26.56%11.5M | -73.64%4.29M | -52.39%7.99M | 88.72%16.79M | -16.27%14.15M |
| Current changes in cash | -51.33%-2.85M | -131.23%-2.24M | 99.51%-17K | 93.16%-612K | 63.47%-2.42M | -41.91%-1.89M | 1,437.50%7.17M | -678.48%-3.47M | -217.16%-8.94M | -1,296.42%-6.63M |
| Effect of exchange rate changes | -99.15%3K | 297.62%167K | 138.96%90K | -468.87%-557K | -252.65%-719K | 300.57%351K | 156.00%42K | -230.00%-231K | -41.25%151K | 32.68%471K |
| End cash Position | -80.20%1.97M | -58.05%4.82M | 60.78%6.9M | -14.63%6.82M | -14.63%6.82M | -29.60%9.97M | -26.56%11.5M | -73.64%4.29M | -52.39%7.99M | -52.39%7.99M |
| Free cash from | -30.91%-2.49M | -61.30%-2.28M | 13.62%-3.01M | -1.03%-9.22M | 63.48%-2.43M | -38.41%-1.9M | -143.28%-1.41M | -564.12%-3.48M | -288.42%-9.12M | -1,248.48%-6.65M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.